Two things I encountered today, good and bad in equal measures. First, the good.
In the recent past, I received an invitation for reviewing a submitted manuscript from a noted journal (which shall remain nameless). The topic of the study verged on pharmacognosy and ethnobotany, both areas of knowledge that I – as an erstwhile drug discovery researcher in another lifetime – find fascinating. I accepted the invitation to review because the study piqued my interest.